Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)-A Potential Target to Treat Metabolic Disorders
Citation
Javed, K, Cheng, Q, Carroll, A et al 2018, 'Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)-A Potential Target to Treat Metabolic Disorders', International Journal of Molecular Sciences, vol. 19, no. 11, pp. 22pp.Year
2018ANU Authors
Field of Research
- Biochemistry And Cell Biology Not Elsewhere Classified